SOURCE: BioPharm Insight

November 16, 2009 09:32 ET

BioPharm Insight and i3 Pharma Informatics Announce Clinical Information Alliance

i3 Pharma Informatics to Contribute Prescription Claims and J Code Data, Deepening the Physician Profiles Provided by BioPharm Insight

NORWOOD, MA--(Marketwire - November 16, 2009) - BioPharm Insight™, a division of Pearson PLC (NYSE: PSO), and i3 Pharma Informatics today announced an alliance that will bring healthcare claims information to clinical operations professionals, assisting in patient enrollment, physician and site selection, and feasibility analysis.

"i3 Pharma Informatics is the provider of investigator and site information based on patient counts from a large database of information relating to private claims. They are often the last, best hope for rescuing a trial from enrollment failures. This one of a kind alliance allows us to include information on investigators and sites from claims data in our clinical operations database, BioPharm Clinical, significantly enriching our physician profiles. In my experience in the information business, this represents the holy grail -- the data is proprietary, highly relevant to the needs of the end user, and helps solve a mission critical need which is optimizing the patient recruitment process," said Sean Power, President and Founder of BioPharm Insight.

BioPharm Clinical will now allow clinical operations professionals to:

--  Identify physician investigators based upon prescribing volumes of
    specific drugs or therapeutic classes, key indicators of underlying patient
--  Search on place of service (POS) and J Code information -- critical
    information for biologic, oncology, or other physician administered drugs;
--  Profile physicians based on multiple criteria, including clinical
    trials experience, historical results, AND potential underlying patient
--  Obtain additional analytics on finding patients through i3.

Thomas Abbott, President of i3 Pharma Informatics, said, "BioPharm Insight has long been recognized as a premier information provider to our shared biotech and pharmaceutical client base. They are the most innovative miner of information out of disparate data sources, and the insight they can develop using their technologies is quite remarkable. I am sure that the combination of our unique skill sets will be a win-win, not only for us, but for the industry as a whole."

Bill Gwinn, Vice-President of Clinical Informatics at i3, commented, "By providing the investigator and site information from claims data from a large medical insurance company in the U.S., i3 has made BioPharm Insight a rich starting point for planning a clinical trial. When needed, i3 can go further in customized analysis, showing the count of patients by doctor who exactly match all the criteria in a trial protocol. Our studies prove that the top-ranking investigators enroll patients twice as fast."

BioPharm Clinical™ Availability

The new release of BioPharm Clinical, including the prescription and J Code claims data from i3 Pharma Informatics, is now available for purchase. For a free trial and for more information, please visit:

About BioPharm Insight™

BioPharm Insight is a wholly-owned subsidiary of the Financial Times Group, publisher of the Financial Times newspaper and FT Group is a division of Pearson plc (NYSE: PSO), the international media group. BioPharm Insight provides daily intelligence on the pharmaceutical, biotech, and medical device industries. Our product suite includes BioPharm Clinical for clinical operations, Pharmawire for financial professionals, and BioPharm Insight for business development. For product and sales information, write to or visit:

About i3

i3, a global Ingenix company, provides integrated scientific strategies and solutions throughout the pharmaceutical product lifecycle. i3 Pharma Informatics is a data, science, and technology provider of market analytics. i3 helps companies gain sharper insights that lead to better patient care. For more information, visit

Contact Information

    Brian Smith
    Marketing Manager
    Email Contact